Business News SMT Launches Hydra TAVI System in Russia Offering Advanced Care for Aortic Stenosis Patients

The company’s innovative approach to TAVI has garnered significant attention from Russian healthcare professionals and patients alike.

A New Era in Aortic Stenosis Treatment

The launch of Hydra TAVI system marks a significant milestone in the Russian healthcare landscape, as it offers a game-changing solution for patients suffering from severe aortic stenosis. Aortic stenosis is a condition where the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes narrowed, restricting blood flow and potentially leading to heart failure.

Benefits of TAVI

TAVI procedures have gained popularity in recent years due to their numerous benefits, including:

Minimally invasive nature, reducing the risk of complications and hospital stays

Reduced risk of bleeding and blood transfusions

Lower risk of stroke and other complications associated with traditional open-heart surgery

Faster recovery times, allowing patients to return to their normal activities sooner

A New Standard in TAVI

The Hydra TAVI system is designed to provide a more precise and effective treatment for severe aortic stenosis. Its innovative design and cutting-edge technology enable surgeons to implant the valve in a minimally invasive manner, reducing the risk of complications and improving patient outcomes.

Expert Endorsement

Russian healthcare professionals have welcomed the launch of Hydra TAVI system, citing its potential to revolutionize the treatment of severe aortic stenosis. “The Hydra TAVI system is a game-changer for patients with severe aortic stenosis,” said Dr.

Hydra Revolutionizes Aortic Valve Replacement with Advanced Technology and Customizable Prosthetic Valves.

Key Features of Hydra

Advanced Valve Design: Hydra’s unique valve design allows for precise control over the valve’s opening and closing, ensuring optimal blood flow and minimizing the risk of complications. Customizable Prosthetic Valves: The system enables the use of customizable prosthetic valves, which can be tailored to individual patient needs and preferences. Real-time Monitoring: Hydra’s advanced monitoring system provides real-time feedback on valve function, allowing for immediate adjustments and minimizing the risk of complications. * Reduced Bleeding Risk: The system’s design reduces the risk of bleeding during and after the procedure, minimizing the need for blood transfusions and reducing the risk of complications. ## Benefits of Hydra for Patients**

Benefits of Hydra for Patients

Improved Outcomes: Hydra’s advanced technology and customizable prosthetic valves can lead to improved patient outcomes, including reduced morbidity and mortality rates. Increased Patient Comfort: The system’s real-time monitoring and adjustable valve design can help reduce patient discomfort and anxiety during and after the procedure. Reduced Recovery Time: Hydra’s advanced technology can help reduce recovery time, allowing patients to return to their normal activities more quickly. ## Benefits of Hydra for Healthcare Providers**

Benefits of Hydra for Healthcare Providers

Improved Procedure Success Rates: Hydra’s advanced technology and customizable prosthetic valves can lead to improved procedure success rates, reducing the need for repeat procedures and minimizing the risk of complications.

The Russian government has implemented various measures to ensure the safety and efficacy of medical devices, including the establishment of a national database of medical devices.

Medical Device Regulation in Russia

Overview of Roszdravnadzor

The Federal Service for Surveillance in Healthcare, Roszdravnadzor, is the primary agency responsible for regulating medical devices in Russia. Established in 2007, Roszdravnadzor is a federal agency that oversees the registration, monitoring, and quality control of medical devices. The agency’s main goal is to ensure the safety and efficacy of medical devices used in healthcare settings.

Registration and Monitoring

To ensure compliance with regulatory requirements, medical device manufacturers in Russia must register their products with Roszdravnadzor.

TAVI gains traction in Russia as demand for minimally invasive aortic valve treatments surges.

The Rise of TAVI in Russia

TAVI, or Transcatheter Aortic Valve Implantation, has been gaining significant attention in Russia in recent years. This minimally invasive procedure has been shown to be an effective solution for patients with severe aortic stenosis, a condition where the aortic valve narrows, restricting blood flow from the heart. Key benefits of TAVI include:

Reduced risk of complications compared to traditional open-heart surgery
Smaller incision size, resulting in less tissue damage and faster recovery times
Ability to treat complex cardiac cases that may be unsuitable for traditional surgery

The Russian Market and Hydra’s Entry

Hydra, a cutting-edge TAVI system, has entered the Russian market at a time when demand for this technology is on the rise.